Stock Report

Download full stock data and analysis for free Last Updated: 15-Nov-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Standard Medical & Pharm Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 511042

₹ --

₹ -- (--%)

As on --

Market cap

info icon

₹3 Cr

Revenue (TTM)

info icon

₹-- Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 75.00 25.00 -122.22 20.68 11.36
Net Profit 75.00 25.00 -335.29 25.44 10.83
EPS 74.77 24.32 -335.03 25.44 10.85
Book Value -- -- -0.01 -2.97 -2.14
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-17Mar-16
EBIT-Margin info ----------
Net Margin info ---460.34------
Return on equity info 0.000.00--0.000.00
Return on Capital info -46.22-29.87--0.000.00
Return on Assets info -63.29-39.64-363.64-12.17-70.55
Debt to Equity (x) info -----0.99-0.99-0.99

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
--
-138.65
-5.33
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
--
--
--
Peer Median
3.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-363.64

Lower than Peers by 365.12

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
-363.64
-12.17
-70.55
-107.14
-4.29
Peer Median
1.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
-3.58
-16.09
-6,421.41
-611.31
Peer Median
2.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-122.22

Lower than Peers by 130.53

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
-122.22
41.09
57.62
-3.14
7.52
Peer Median
8.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-335.29

Lower than Peers by 353.69

Year on year growth in profit after tax

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
-335.29
85.33
99.44
-1,152.72
-5.17
Peer Median
18.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-335.03

Lower than Peers by 347.93

Year on year growth in earnings per share

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
-335.03
85.90
99.44
-1,152.69
-5.17
Peer Median
12.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
-0.01
0.17
-9.23
-0.74
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

-0.99

Lower than Peers by 0.99

Total debt / Net worth

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
-0.99
-0.99
-0.99
-0.99
-1.14
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

--

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
0.01
0.02
0.03
Peer Median
2.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
0.01
0.02
0.03
Peer Median
2.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
--
--
--
Peer Median
8.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-17
Mar-16
Mar-15
Mar-14
Standard Medical & Pharm
--
--
--
--
--
Peer Median
0.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month